Etudes de cas

Découvrez dans cette sélection d’études de cas quelques exemples de solutions mises en oeuvre pour relever les défis
de projets complexes et parfois atypiques

Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.

Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.

Lire l’étude de cas
A First-In-Human trial of monoclonal antibody IMP in patients with Anti-Müllerian-Hormone-Receptor II (AMHRII) positive gynecological cancers

A First-In-Human trial of monoclonal antibody IMP in patients with Anti-Müllerian-Hormone-Receptor II (AMHRII) positive gynecological cancers

Lire l’étude de cas
Lung cancer patients treated with a new PD-1 IMP: A longitudinal, prospective, observational, multicentric study in France

Lung cancer patients treated with a new PD-1 IMP: A longitudinal, prospective, observational, multicentric study in France

Lire l’étude de cas
A Prospective study on an IMP PET/CT Imaging in Biochemical Recurrence of Prostate Cancer

A Prospective study on an IMP PET/CT Imaging in Biochemical Recurrence of Prostate Cancer

Lire l’étude de cas
Pain relief and protection of three self-treated dermatological foot conditions

Pain relief and protection of three self-treated dermatological foot conditions

Lire l’étude de cas
Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.

Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.

Lire l’étude de cas
Derived cell ATMP implantation for the treatment of fecal incontinence: a multicentre, randomized, double-blind, placebo-controlled, parallel-group, dose-finding clinical study.

Derived cell ATMP implantation for the treatment of fecal incontinence: a multicentre, randomized, double-blind, placebo-controlled, parallel-group, dose-finding clinical study.

Lire l’étude de cas
A phase 1/2, open-label, safety, tolerability and preliminary efficacy study of implantation into one eye of an ATMP in patients with retinitis pigmentosa due to monogenic mutation

A phase 1/2, open-label, safety, tolerability and preliminary efficacy study of implantation into one eye of an ATMP in patients with retinitis pigmentosa due to monogenic mutation

Lire l’étude de cas
Long-Term Safety Evaluation of a Medicinal Product in Inherited Haematological Disorder in Europe

Long-Term Safety Evaluation of a Medicinal Product in Inherited Haematological Disorder in Europe

Lire l’étude de cas
Prevention & Treatment of a non-serious dermatological condition on the foot

Prevention & Treatment of a non-serious dermatological condition on the foot

Lire l’étude de cas
RGPD compliant
21 CFR Part 11 compliance
crédit d'impôt recherche
bureau veritas certification icta
bureau veritas certification icta